"Great framework. But what about [vendor name]?" I got that question dozens of times. From CDOs, commercial leads, even vendors themselves. Adobe, Salesforce, and Veeva dominate pharma CX conversations. But the Big Three report proved what many suspected: no single vendor scores above 4.0 across all five dimensions. If your CX architecture inevitably involves multiple platforms (and it will), evaluating only the obvious three is like grading a group project by checking three

The answer? Nobody. I assessed Adobe, Salesforce, and Veeva across 𝟯𝟭 𝘀𝘂𝗯-𝗰𝗿𝗶𝘁𝗲𝗿𝗶𝗮 in 𝟱 𝗱𝗶𝗺𝗲𝗻𝘀𝗶𝗼𝗻𝘀. Scored each 1 to 5. Verified against 60+ sources. The result is... uncomfortable. Here is what I can tell you: 𝟭. No single vendor scores above 4.0 across all dimensions. Not one. 𝟮. The spread within a single vendor is brutal. One scores 4.86 in one dimension and 2.17 in another. Same company. Same platform. 𝟯. The vendor with the highest overall sco

I mapped every subscription tier from OpenAI, Anthropic, Google, and Mistral against four questions a pharma board needs answered before any AI procurement decision. The result is sobering. 𝗧𝗵𝗲 𝟰 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀: 𝟭. Does the provider train on our inputs by default? 𝟮. Can we lawfully process EU personal data on this tier (GDPR)? 𝟯. Can we lawfully process US patient data on this tier (HIPAA)? 𝟰. Is DPA + BAA + Zero Data Retention available on the same tier? 𝗧𝗵𝗲

Why AI fails not because of technology, but because the organization was never redesigned for it. My nine-year-old recently asked me why her LEGO spaceship keeps falling apart. I told her the pieces are fine. The blueprint is wrong. She looked at me like I was stating the obvious. She is right. It is obvious. And yet, most companies deploying AI are making the exact same mistake: they keep buying better pieces while ignoring the blueprint. Moderna merged HR and IT into a sing